MYC and ovarian carcinoma: Consistent with this premise, antisense oligodeoxynucleotides or the silencing of MYC by small-interfering RNA increases cisplatin sensitivity in inherently cisplatin-resistant melanoma cell lines in vitro and reduces tumor formation in xenograft models of cisplatin-resistant ovarian cancer cells [117,119].